Modelling the impact of initiation delay, duration and prior PrEP on the efficacy of post‐exposure prophylaxis containing a tenofovir/emtricitabine backbone

Introduction Pre‐ and post‐exposure prophylaxis (PrEP and PEP) are important pillars of the HIV prevention portfolio to reduce the risk of acquisition just before or after HIV exposure. While PrEP efficacy has been elucidated in many randomized clinical trials, corresponding data for PEP is extremel...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of the International AIDS Society Jg. 28; H. S1; S. e26454 - n/a
Hauptverfasser:	Zhang, Lanxin, Collins, Simon, Fox, Julie, Kleist, Max
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	Switzerland John Wiley & Sons, Inc 01.06.2025 John Wiley and Sons Inc Wiley
Schlagworte:	Anti-HIV Agents - administration & dosage Anti-HIV Agents - pharmacokinetics Antiretroviral drugs Binomial distribution Chemoprevention - methods Clinical trials Disease prevention Drug dosages Emtricitabine - administration & dosage Emtricitabine - pharmacokinetics Emtricitabine - therapeutic use Exposure Health risks HIV HIV Infections - prevention & control Human immunodeficiency virus Humans Infections Male mathematical modelling Mathematical models Ordinary differential equations Pharmacokinetics Post-Exposure Prophylaxis - methods post‐exposure prophylaxis Pre-Exposure Prophylaxis - methods pre‐exposure prophylaxis Probability Prophylaxis quantitative systems pharmacology Risk reduction TDF/FTC Tenofovir - administration & dosage Tenofovir - pharmacokinetics Time Factors Treatment Outcome Vagina Viruses pre‐exposure prophylaxis TDF/FTC mathematical modelling HIV post‐exposure prophylaxis quantitative systems pharmacology
ISSN:	1758-2652, 1758-2652
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!